UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Salvage prostate bed plus elective pelvic node radiation without androgen deprivation therapy

Journal of cancer research and clinical oncology, 2023-11, Vol.149 (14), p.13231-13237

2023

Volltextzugriff (PDF)

Validation of a Cell-Cycle Progression Gene Panel to Improve Risk Stratification in a Contemporary Prostatectomy Cohort

Journal of clinical oncology, 2013-04, Vol.31 (11), p.1428-1434

2013

Volltextzugriff (PDF)

Randomized Phase III Noninferiority Study Comparing Two Radiotherapy Fractionation Schedules in Patients With Low-Risk Prostate Cancer

Journal of clinical oncology, 2016-07, Vol.34 (20), p.2325-2332

2016

Volltextzugriff (PDF)

Cell‐cycle risk score more accurately determines the risk for metastases and death in prostatectomy patients compared with clinical features alone

The Prostate, 2021-03, Vol.81 (4), p.261-267

2021

Volltextzugriff (PDF)

Arcjet Evaluation of Thermocouple Performance in Flexible Thermal Protection System Materials

Journal of spacecraft and rockets, 2023-07, Vol.60 (4), p.1308-1318

2023

Volltextzugriff (PDF)

Electrical Shorting of Thermocouples in Flexible Thermal Protection System Materials

Journal of spacecraft and rockets, 2023-03, Vol.60 (2), p.591-600

2023

Volltextzugriff (PDF)

Gleason Score Evolution and the Effect on Prostate Cancer Outcomes

American journal of clinical pathology, 2021-05, Vol.155 (5), p.711-717

2021

Volltextzugriff (PDF)

Adjuvant Radiotherapy for Pathological T3N0M0 Prostate Cancer Significantly Reduces Risk of Metastases and Improves Survival: Long-Term Followup of a Randomized Clinical Trial

The Journal of urology, 2009-03, Vol.181 (3), p.956-962

2009

Volltextzugriff (PDF)

Final Report of the Intergroup Randomized Study of Combined Androgen-Deprivation Therapy Plus Radiotherapy Versus Androgen-Deprivation Therapy Alone in Locally Advanced Prostate Cancer

Journal of clinical oncology, 2015-07, Vol.33 (19), p.2143-2150

2015

Volltextzugriff (PDF)

Predominant Treatment Failure in Postprostatectomy Patients Is Local: Analysis of Patterns of Treatment Failure in SWOG 8794

Journal of clinical oncology, 2007-06, Vol.25 (16), p.2225-2229

2007

Volltextzugriff (PDF)

Reference Results for Blood Parameter Changes and Recovery after Pelvic Radiation without Chemotherapy

Hematology reports, 2022-05, Vol.14 (2), p.155-164

2022

Volltextzugriff (PDF)

Long-Term Analysis of NRG Oncology RTOG 0415: A Randomized Phase III Noninferiority Study Comparing Two Fractionation Schedules in Patients With Low-Risk Prostate Cancer

Journal of clinical oncology, 2024-07, Vol.42 (20), p.2377-2381

2024

Volltextzugriff (PDF)

A Phase 1/2 Trial of a Combination of Paclitaxel and Trastuzumab With Daily Irradiation or Paclitaxel Alone With Daily Irradiation After Transurethral Surgery for Noncystectomy Candidates With Muscle-Invasive Bladder Cancer (Trial NRG Oncology RTOG 0524)

International journal of radiation oncology, biology, physics, 2017-04, Vol.97 (5), p.995-1001

2017

Volltextzugriff (PDF)

Pathologic findings at radical prostatectomy: Risk factors for failure and death

Urologic oncology, 2007-03, Vol.25 (2), p.110-114

2007

Volltextzugriff (PDF)

Adjuvant Androgen Deprivation for High-Risk Prostate Cancer After Radical Prostatectomy: SWOG S9921 Study

Journal of clinical oncology, 2011-05, Vol.29 (15), p.2040-2045

2011

Volltextzugriff (PDF)

Phase III Intergroup Trial of Adjuvant Androgen Deprivation With or Without Mitoxantrone Plus Prednisone in Patients With High-Risk Prostate Cancer After Radical Prostatectomy: SWOG S9921

Journal of clinical oncology, 2018-05, Vol.36 (15), p.1498-1504

2018

Volltextzugriff (PDF)

Pathological characteristics of low risk prostate cancer based on totally embedded prostatectomy specimens

The Prostate, 2015-03, Vol.75 (4), p.424-429

2015

Volltextzugriff (PDF)

The effect of pelvic radiation alone on lymphocyte subgroups

Clinical and translational radiation oncology, 2020-07, Vol.23, p.100-102

2020

Volltextzugriff (PDF)

Ad Astra - telomeres in space

International journal of radiation biology, 2022-03, Vol.98 (3), p.395-403

2022

Volltextzugriff (PDF)

Suppression of ribosomal protein RPS6KB1 by Nexrutine increases sensitivity of prostate tumors to radiation

Cancer letters, 2018-10, Vol.433, p.232-241

2018

Volltextzugriff (PDF)

Long-Term Follow-Up after Prostatectomy for Prostate Cancer and the Need for Active Monitoring

Prostate cancer, 2020, Vol.2020 (2020), p.1-6

2020

Volltextzugriff (PDF)

NTCP Modeling and Dose-Volume Correlations of Significant Hematocrit Drop 3 Months After Prostate Radiation Therapy

Advances in radiation oncology, 2024-03, Vol.9 (3), p.101393, Article 101393

2024

Volltextzugriff (PDF)

Tolerance doses for late adverse events after hypofractionated radiotherapy for prostate cancer on trial NRG Oncology/RTOG 0415

Radiotherapy and oncology, 2019-06, Vol.135, p.19-24

2019

Volltextzugriff (PDF)

Prostate-specific Antigen Mass Density—A Measure Predicting Prostate Cancer Volume and Accounting for Overweight and Obesity-related Prostate-specific Antigen Hemodilution

Urology (Ridgewood, N.J.), 2016-04, Vol.90, p.141-147

2016

Volltextzugriff (PDF)

1 – 25 von 532

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(481)
Mit Volltextzugriff
(422)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Salvage prostate bed plus elective pelvic node radiation without androgen deprivation therapy

Validation of a Cell-Cycle Progression Gene Panel to Improve Risk Stratification in a Contemporary Prostatectomy Cohort

Randomized Phase III Noninferiority Study Comparing Two Radiotherapy Fractionation Schedules in Patients With Low-Risk Prostate Cancer

Prognostic value of an RNA expression signature derived from cell cycle proliferation genes in patients with prostate cancer: a retrospective study

Cell‐cycle risk score more accurately determines the risk for metastases and death in prostatectomy patients compared with clinical features alone

Arcjet Evaluation of Thermocouple Performance in Flexible Thermal Protection System Materials

Electrical Shorting of Thermocouples in Flexible Thermal Protection System Materials

Gleason Score Evolution and the Effect on Prostate Cancer Outcomes

Adjuvant Radiotherapy for Pathological T3N0M0 Prostate Cancer Significantly Reduces Risk of Metastases and Improves Survival: Long-Term Followup of a Randomized Clinical Trial

Final Report of the Intergroup Randomized Study of Combined Androgen-Deprivation Therapy Plus Radiotherapy Versus Androgen-Deprivation Therapy Alone in Locally Advanced Prostate Cancer

Predominant Treatment Failure in Postprostatectomy Patients Is Local: Analysis of Patterns of Treatment Failure in SWOG 8794

Reference Results for Blood Parameter Changes and Recovery after Pelvic Radiation without Chemotherapy

Long-Term Analysis of NRG Oncology RTOG 0415: A Randomized Phase III Noninferiority Study Comparing Two Fractionation Schedules in Patients With Low-Risk Prostate Cancer

A Phase 1/2 Trial of a Combination of Paclitaxel and Trastuzumab With Daily Irradiation or Paclitaxel Alone With Daily Irradiation After Transurethral Surgery for Noncystectomy Candidates With Muscle-Invasive Bladder Cancer (Trial NRG Oncology RTOG 0524)

Pathologic findings at radical prostatectomy: Risk factors for failure and death

Adjuvant Androgen Deprivation for High-Risk Prostate Cancer After Radical Prostatectomy: SWOG S9921 Study

Phase III Intergroup Trial of Adjuvant Androgen Deprivation With or Without Mitoxantrone Plus Prednisone in Patients With High-Risk Prostate Cancer After Radical Prostatectomy: SWOG S9921

Pathological characteristics of low risk prostate cancer based on totally embedded prostatectomy specimens

The effect of pelvic radiation alone on lymphocyte subgroups

Ad Astra - telomeres in space

Suppression of ribosomal protein RPS6KB1 by Nexrutine increases sensitivity of prostate tumors to radiation

Long-Term Follow-Up after Prostatectomy for Prostate Cancer and the Need for Active Monitoring

NTCP Modeling and Dose-Volume Correlations of Significant Hematocrit Drop 3 Months After Prostate Radiation Therapy

Tolerance doses for late adverse events after hypofractionated radiotherapy for prostate cancer on trial NRG Oncology/RTOG 0415

Prostate-specific Antigen Mass Density—A Measure Predicting Prostate Cancer Volume and Accounting for Overweight and Obesity-related Prostate-specific Antigen Hemodilution

Suchergebnisse filtern